Standard Medicare Part B Management Empliciti
Customize your policy alerts
Sign up for clover_health Policy 4858-A alerts
Get alerted when Policy 4858-A changes without checking for updates manually.
Monitor payer policy activity
This policy governs prior authorization and coverage of Empliciti (elotuzumab), including FDA-approved and specified compendial uses, for Clover Health Medicare Part B members. Coverage applies when the applicable disease, prior-therapy, combination-regimen, and continuation criteria are met.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.